+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Polycystic Kidney Disease Market

  • PDF Icon

    Report

  • 200 Pages
  • May 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5968539
The global polycystic kidney disease market accounted for USD 0.541 billion in 2023 and is expected to reach at USD 1.01 billion by 2034 with a CAGR of 5.82% during the forecast period 2024-2034. The rising incidence of kidney failure, advances in genetic research, increased awareness and screening programs, technological advances in imaging, regulatory incentives, and orphan drug designations will all fuel market expansion.

Advances in imaging technology, such as magnetic resonance imaging (MRI) and ultrasound, have improved PKD detection and monitoring. These imaging methods enable the visibility and characterization of kidney cysts, which aids in diagnosis, disease monitoring, and therapy planning. Imaging technology developments continue to improve PKD management and patient care. For instance, in December 2023, Otsuka reported good findings from a Phase 3 research of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD).

By type, the autosomal dominant PKD (ADPKD) segment accounted for the highest revenue-grossing segment in the global polycystic kidney disease market in 2023 owing to the increased prevalence, greater awareness, and the availability of targeted therapies specifically designed to address the underlying genetic mechanisms of ADPKD. For instance, in September 2023, Pfizer announced the start of a Phase 2 trial for its investigational medication, PF-7191, to treat ADPKD. Additionally, the other segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of novel treatment options, expanding research and development activities, and increasing focus on addressing unmet needs in less common forms of polycystic kidney disease.

By treatment, the medication segment accounted for the highest revenue-grossing segment in the global polycystic kidney disease market in 2023 owing to the growing demand for pharmacological interventions aimed at managing symptoms, slowing disease progression, and improving quality of life for patients with polycystic kidney disease. For instance, in August 2023, Novartis gained FDA approval for Tovok (tolvaptan) to treat ADPKD in children aged 2 to 5 years. Additionally, the other segment is predicted to grow at the fastest CAGR during the forecast period owing to the emerging advancements in gene therapy technologies, promising preclinical and clinical trial results, and increasing investment in research and development for genetic-based treatments targeting polycystic kidney disease.

By diagnosis, the ultrasound segment accounted for the highest revenue-grossing segment in the global polycystic kidney disease market in 2023 owing to the reliability, accessibility, and cost-effectiveness of ultrasound imaging for diagnosing and monitoring polycystic kidney disease, leading to widespread adoption across healthcare settings. For instance, in November 2023, Bayer reported favorable Phase 3 findings for finerenone in patients with chronic kidney disease (including ADPKD). Additionally, the MRI scan segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for higher-resolution imaging, improved accuracy in cyst detection and characterization, and expanding applications of MRI technology in diagnosing and monitoring polycystic kidney disease.

By route of administration, the oral segment accounted for the highest revenue-grossing segment in the global polycystic kidney disease market in 2023 owing to the convenience, patient preference, and widespread availability of oral medications for managing symptoms and slowing disease progression in polycystic kidney disease. For instance, in January 2024, Bristol Myers Squibb reported encouraging results from their Phase 2 trial of Orencia (abatacept) in ADPKD patients. Additionally, the parenteral segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing development of injectable formulations offering improved bioavailability, faster onset of action, and better treatment outcomes for polycystic kidney disease.

By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global polycystic kidney disease market in 2023 owing to the high patient volumes, advanced medical infrastructure, and comprehensive healthcare services offered by hospitals for the diagnosis, treatment, and management of polycystic kidney disease. For instance, in December 2023, Teva got FDA approval for their generic version of tolvaptan tablets to treat ADPKD. Additionally, the specialty clinics segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing focus on personalized care, specialized expertise, and a multidisciplinary approach to managing polycystic kidney disease, driving patients' preference for specialty clinics.

North American region is anticipated to have the highest revenue share during the forecast period owing to the advanced healthcare infrastructure, high prevalence of polycystic kidney disease, increasing adoption of novel treatments, and favorable reimbursement policies in the North American region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising awareness about polycystic kidney disease, improving healthcare infrastructure, increasing disposable income, and expanding access to healthcare services in the Asia Pacific region. For instance, in February 2024, AstraZeneca announced the start of a Phase 3 trial of anifrolumab in patients with lupus nephritis, a disease that can arise in PKD.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Type, Treatment, Diagnosis, Route of Administration, and End-User
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players

Segmentation: Polycystic Kidney Disease Market Report 2023 - 2034

Polycystic Kidney Disease Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)

  • Autosomal Dominant Polycystic Kidney Disease
  • Autosomal Recessive Polycystic Kidney Disease
  • Others

Polycystic Kidney Disease Market Analysis & Forecast by Treatment 2023 - 2034 (Revenue USD Bn)

  • Medication
  • Surgery
  • Others

Polycystic Kidney Disease Market Analysis & Forecast by Diagnosis 2023 - 2034 (Revenue USD Bn)

  • Ultrasound
  • CT Scan
  • MRI Scan

Polycystic Kidney Disease Market Analysis & Forecast by Route of Administration 2023 - 2034 (Revenue USD Bn)

  • Oral
  • Parenteral
  • Others

Polycystic Kidney Disease Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)

  • Hospital
  • Speciality Clinics
  • Others

Polycystic Kidney Disease Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Polycystic Kidney Disease Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Polycystic Kidney Disease Market: Type Estimates & Trend Analysis
7.1. Type Segment Opportunity Analysis
7.2. Autosomal Dominant Polycystic Kidney Disease
7.2.1. Autosomal Dominant Polycystic Kidney Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Autosomal Recessive Polycystic Kidney Disease
7.3.1. Autosomal Recessive Polycystic Kidney Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Others
7.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Polycystic Kidney Disease Market: Treatment Estimates & Trend Analysis
8.1. Treatment Segment Opportunity Analysis
8.2. Medication
8.2.1. Medication Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Surgery
8.3.1. Surgery Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Others
8.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Polycystic Kidney Disease Market: Diagnosis Estimates & Trend Analysis
9.1. Diagnosis Segment Opportunity Analysis
9.2. Ultrasound
9.2.1. Ultrasound Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. CT Scan
9.3.1. CT Scan Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. MRI Scan
9.4.1. MRI Scan Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Polycystic Kidney Disease Market: Route of Administration Estimates & Trend Analysis
10.1. Diagnosis Segment Opportunity Analysis
10.2. Oral
10.2.1. Oral Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.3. Parenteral
10.3.1. Parenteral Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.4. Others
10.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11. Polycystic Kidney Disease Market: End-user Estimates & Trend Analysis
11.1. End-user Segment Opportunity Analysis
11.2. Hospital
11.2.1. Hospital Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3. Speciality Clinics
11.3.1. Speciality Clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.4. Others
11.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
12. Regional Market Analysis
12.1. Regional Market Opportunity Analysis
13. North America Polycystic Kidney Disease Market
13.1. North America Polycystic Kidney Disease Market
13.1.1. North America Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. North America Polycystic Kidney Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. North America Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.1.4. North America Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.1.5. North America Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
13.1.6. North America Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.1.7. North America Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. U.S. Global Polycystic Kidney Disease Market
13.2.1. U.S. Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. U.S. Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.2.3. U.S. Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.2.4. U.S. Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
13.2.5. U.S. Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.2.6. U.S. Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. Canada Global Polycystic Kidney Disease Market
13.3.1. Canada Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. Canada Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.3.3. Canada Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.3.4. Canada Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
13.3.5. Canada Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.3.6. Canada Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Europe Global Polycystic Kidney Disease Market
14.1. Europe Global Polycystic Kidney Disease Market
14.1.1. Europe Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Europe Polycystic Kidney Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Europe Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.1.4. Europe Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.1.5. Europe Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
14.1.6. Europe Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.1.7. Europe Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Germany Global Polycystic Kidney Disease Market
14.2.1. Germany Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Germany Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.2.3. Germany Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.2.4. Germany Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
14.2.5. Germany Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.2.6. Germany Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. UK Global Polycystic Kidney Disease Market
14.3.1. UK Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. UK Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.3.3. UK Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.3.4. UK Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
14.3.5. UK Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.3.6. UK Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. France Global Polycystic Kidney Disease Market
14.4.1. France Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. France Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.4.3. France Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.4.4. France Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
14.4.5. France Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.4.6. France Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. Spain Global Polycystic Kidney Disease Market
14.5.1. Spain Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Spain Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.5.3. Spain Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.5.4. Spain Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
14.5.5. Spain Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.5.6. Spain Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.6. Italy Global Polycystic Kidney Disease Market
14.6.1. Italy Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.6.2. Italy Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.6.3. Italy Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.6.4. Italy Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
14.6.5. Italy Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.6.6. Italy Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.7. Rest of Europe Global Polycystic Kidney Disease Market
14.7.1. Rest of Europe Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.7.2. Rest of Europe Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.7.3. Rest of Europe Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.7.4. Rest of Europe Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
14.7.5. Rest of Europe Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.7.6. Rest of Europe Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. Asia Pacific Global Polycystic Kidney Disease Market
15.1. Asia Pacific Global Polycystic Kidney Disease Market
15.1.1. Asia Pacific Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.1.4. Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.1.5. Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
15.1.6. Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.1.7. Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. Japan Global Polycystic Kidney Disease Market
15.2.1. Japan Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. Japan Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.2.3. Japan Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.2.4. Japan Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
15.2.5. Japan Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.2.6. Japan Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. China Global Polycystic Kidney Disease Market
15.3.1. China Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. China Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.3.3. China Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.3.4. China Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
15.3.5. China Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.3.6. China Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. India Global Polycystic Kidney Disease Market
15.4.1. India Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. India Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.4.3. India Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.4.4. India Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
15.4.5. India Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.4.6. India Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.5. South Korea Global Polycystic Kidney Disease Market
15.5.1. South Korea Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.5.2. South Korea Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.5.3. South Korea Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.5.4. South Korea Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
15.5.5. South Korea Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.5.6. South Korea Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.6. Australia Global Polycystic Kidney Disease Market
15.6.1. Australia Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.6.2. Australia Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.6.3. Australia Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.6.4. Australia Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
15.6.5. Australia Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.6.6. Australia Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.7. Rest of Asia Pacific Global Polycystic Kidney Disease Market
15.7.1. Rest of Asia Pacific Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.7.2. Rest of Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.7.3. Rest of Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.7.4. Rest of Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
15.7.5. Rest of Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.7.6. Rest of Asia Pacific Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Latin America Global Polycystic Kidney Disease Market
16.1. Latin America Global Polycystic Kidney Disease Market
16.1.1. Latin America Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.1.2. Latin America Polycystic Kidney Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
16.1.3. Latin America Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.1.4. Latin America Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
16.1.5. Latin America Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
16.1.6. Latin America Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.1.7. Latin America Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.2. Brazil Global Polycystic Kidney Disease Market
16.2.1. Brazil Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.2.2. Brazil Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.2.3. Brazil Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
16.2.4. Brazil Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
16.2.5. Brazil Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.2.6. Brazil Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.3. Mexico Global Polycystic Kidney Disease Market
16.3.1. Mexico Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.3.2. Mexico Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.3.3. Mexico Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
16.3.4. Mexico Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
16.3.5. Mexico Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.3.6. Mexico Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.4. Argentina Global Polycystic Kidney Disease Market
16.4.1. Argentina Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.4.2. Argentina Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.4.3. Argentina Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
16.4.4. Argentina Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
16.4.5. Argentina Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.4.6. Argentina Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.5. Rest of Latin America Global Polycystic Kidney Disease Market
16.5.1. Rest of Latin America Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.5.2. Rest of Latin America Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.5.3. Rest of Latin America Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
16.5.4. Rest of Latin America Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
16.5.5. Rest of Latin America Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.5.6. Rest of Latin America Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17. MEA Global Polycystic Kidney Disease Market
17.1. MEA Global Polycystic Kidney Disease Market
17.1.1. MEA Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.1.2. MEA Polycystic Kidney Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
17.1.3. MEA Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
17.1.4. MEA Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
17.1.5. MEA Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
17.1.6. MEA Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
17.1.7. MEA Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.2. GCC Global Polycystic Kidney Disease Market
17.2.1. GCC Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.2.2. GCC Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
17.2.3. GCC Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
17.2.4. GCC Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
17.2.5. GCC Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
17.2.6. GCC Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.3. South Africa Global Polycystic Kidney Disease Market
17.3.1. South Africa Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.3.2. South Africa Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
17.3.3. South Africa Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
17.3.4. South Africa Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
17.3.5. South Africa Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
17.3.6. South Africa Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.4. Rest of MEA Global Polycystic Kidney Disease Market
17.4.1. Rest of MEA Polycystic Kidney Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.4.2. Rest of MEA Polycystic Kidney Disease Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
17.4.3. Rest of MEA Polycystic Kidney Disease Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
17.4.4. Rest of MEA Polycystic Kidney Disease Market Size and Forecast, By Diagnosis, 2023-2034 (Revenue USD Bn)
17.4.5. Rest of MEA Polycystic Kidney Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
17.4.6. Rest of MEA Polycystic Kidney Disease Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18. Competitor Analysis
18.1. Company Market Share Analysis, 2023
18.2. Major Recent Developments
19. Company Profiles
19.1. Otsuka Pharmaceutical Co., Ltd.
19.2. Sanofi S.A.
19.3. F. Hoffmann-La Roche Ltd.
19.4. Pfizer Inc.
19.5. Novartis International AG
19.6. Bayer AG
19.7. Bristol Myers Squibb Company
19.8. Teva Pharmaceutical Industries Ltd.
19.9. AstraZeneca PLC
19.10. Merck & Co., Inc.
19.11. AbbVie Inc.
19.12. Reata Pharmaceuticals, Inc.
19.13. Kadmon Holdings, Inc.
19.14. Vertex Pharmaceuticals Incorporated
19.15. Ardelyx, Inc.
20. Conclusion21. Recommendations

Companies Mentioned

  • Otsuka Pharmaceutical Co. Ltd.
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Novartis International AG
  • Bayer AG
  • Bristol Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca PLC
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Reata Pharmaceuticals Inc.
  • Kadmon Holdings Inc.
  • Vertex Pharmaceuticals Incorporated
  • Ardelyx Inc.